Trials / Suspended
SuspendedNCT05363436
Opioid Reduction Toolkit Reduces Opioids Prescribed and Consumed
Successful Implementation of an Opioid Reduction Toolkit in Pancreatectomy Patients Significantly Decreases Number of Opioids Prescribed and Consumed
- Status
- Suspended
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 159 (actual)
- Sponsor
- Thomas Jefferson University · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Investigators studied a baseline population of patients receiving pancreatectomies at their institution and determined how many opioid pills each patient was prescribed and how many they took. Based on this data they created a toolkit to provide to prescribers to give patients a modified number of pills. The amount prescribed and consumed was measured after intervention.
Detailed description
A single academic surgical department reviewed opioid treatment patterns for patients undergoing common procedures, including open pancreatectomy, and an opioid reduction toolkit using the data collected was created. Providers were educated on the use of the toolkit and it was implemented as a standard of practice. Data were collected on pancreatectomy patients via telephone interview (performed at 2 weeks post-op) and by reviewing the state prescription drug monitoring program. Outcome variables included morphine milliequivalents (MME) of pills prescribed, MME of pills consumed, number of patients aware of proper unused pill disposal, number of patients requesting refills, and pain scores. Categorical and continuous outcomes were compared within and between groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxycodone | Providers had to prescribe 15 oxycodone pills to each patient discharge |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2028-12-01
- Completion
- 2028-12-01
- First posted
- 2022-05-05
- Last updated
- 2024-04-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05363436. Inclusion in this directory is not an endorsement.